Source link : https://www.newshealth.biz/health-news/azithromycin-fails-to-ease-burden-of-bronchopulmonary-dysplasia-in-preemies/
Azithromycin for premature newborns requiring breathing support failed to improve rates of survival without moderate or severe bronchopulmonary dysplasia at 36 weeks’ postmenstrual age, though it proved safe in a large randomized trial from the U.K. Of nearly 800 infants in the so-called AZTEC study, that primary endpoint occurred in 42% of those prophylactically treated […]
Author : News Health
Publish date : 2024-05-02 19:43:57
Copyright for syndicated content belongs to the linked Source.